NYSE · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · LARGE CAP
Enovis Corp. ENOV
17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$2.2B
▲ 6.7% vs FY2024
EPS · FY25
$-20.75
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-58.5%
Net margin · FY25
-52.7%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 2.2B
Revenue, FY2025 · full 17-year series below
Revenue
Net income
The company lost 53 cents on every revenue dollar this year.
Per share
USD -20.75
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-58.5%
Return on equity, FY2025
ROE
Operating margin-50.0%
Net margin-52.7%
Return on assets-27.7%
Each USD of equity lost 58 cents this year.
Returned to shareholders
USD 2.2M
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 2.2M
Share of profit-0.2%
Consecutive raises—
USD 2.2M in buybacks went back to shareholders in a year without profit.
Growth
+14.9% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+12.9%
+14.9%
−4.1%
+9.9%
Returned to shareholders
−20.4%
+17.1%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.06B
Shares outstanding, FY2025
Change, 5 years−4.0%
Change, 10 years—
The share count shrank 4% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 3.8B
total assets, end of FY2025
Total assetsUSD 3.8B
EquityUSD 1.5B
CashUSD 36.4M
Gross debtUSD 1.3B
Net debtUSD 1.3B
Current ratio2.02×
Net debt stands at 85% of equity.
History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
2.2
2.1
1.7
1.6
1.4
1.1
3.3
2.2
1.9
3.2
3.4
4.6
4.2
3.9
0.7
0.5
0.5
Operating income $B
−1.1
−0.8
−0.1
−0.1
−0.1
−0.1
0.2
0.2
0.1
0.2
0.3
0.4
0.4
0.1
0.0
0.0
0.0
EBITDA $B
0.2
0.2
0.2
0.1
0.1
0.1
0.4
0.2
0.2
0.4
0.4
0.6
0.5
0.3
0.0
0.1
·
Income tax $B
0.0
0.0
−0.0
0.0
−0.0
−0.0
0.0
−0.0
0.0
0.1
0.0
−0.1
0.1
0.1
0.0
0.0
0.0
Net income $B
−1.2
−0.8
−0.0
−0.0
0.1
0.0
−0.5
0.1
0.2
0.1
0.2
0.4
0.2
−0.1
0.0
0.0
0.0
EPS, diluted $
−20.75
−14.93
−0.61
−0.25
1.40
0.93
−3.89
1.16
1.22
1.04
1.34
3.02
1.54
−0.92
0.10
0.37
0.55
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
−0
0
1
·
ROE %
−58.5
−27.6
−1.0
−0.3
1.8
1.2
−15.7
4.1
4.7
4.3
5.4
13.9
8.1
−6.1
2.2
7.5
11.0
Shares out B
0.06
0.06
0.05
0.05
0.05
0.12
0.12
0.12
0.12
0.12
0.12
0.12
0.10
0.09
0.04
0.04
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
64 of 65
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 1 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed